# Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer

> **NCT05184400** · — · RECRUITING · sponsor: **Herlev and Gentofte Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Biliary Tract Cancer
- Cholangiocarcinoma
- Gallbladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05184400
- **Lead sponsor:** Herlev and Gentofte Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2015-01-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05184400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05184400, "Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05184400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*